In Brief: FDA warning letter grace period
This article was originally published in The Gray Sheet
FDA warning letter grace period: Proposal to give firms a 15-day response period after receiving an FDA-483 inspectional observation form prior to issuing a warning letter is slated for discussion at an April meeting of FDA's Field Committee. The change in policy would obviate issuance of a warning letter if a firm corrected all violations during the grace period ("The Gray Sheet" Dec. 22, I&W-5)...
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.